A new trading day began on Tuesday, with Atossa Therapeutics Inc (NASDAQ: ATOS) stock price up 7.00% from the previous day of trading, before settling in for the closing price of $0.62. ATOS’s price has ranged from $0.55 to $1.29 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 36.92% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -25.00%. With a float of $129.10 million, this company’s outstanding shares have now reached $129.17 million.
Atossa Therapeutics Inc (ATOS) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Atossa Therapeutics Inc is 0.06%, while institutional ownership is 19.41%. The most recent insider transaction that took place on May 21 ’25, was worth 9,887. In this transaction President & CEO of this company bought 11,239 shares at a rate of $0.88, taking the stock ownership to the 13,898 shares. Before that another transaction happened on Mar 26 ’25, when Company’s Director bought 10,000 for $0.70, making the entire transaction worth $7,000. This insider now owns 10,257 shares in total.
Atossa Therapeutics Inc (ATOS) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.05 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -25.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -17.57% during the next five years compared to 36.92% growth over the previous five years of trading.
Atossa Therapeutics Inc (NASDAQ: ATOS) Trading Performance Indicators
Here are Atossa Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.23, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.29 in one year’s time.
Technical Analysis of Atossa Therapeutics Inc (ATOS)
Let’s dig in a bit further. During the last 5-days, its volume was 2.09 million. That was better than the volume of 1.69 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 47.53%.
During the past 100 days, Atossa Therapeutics Inc’s (ATOS) raw stochastic average was set at 14.80%, which indicates a significant decrease from 55.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0442 in the past 14 days, which was lower than the 0.0484 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7737, while its 200-day Moving Average is $0.8148. However, in the short run, Atossa Therapeutics Inc’s stock first resistance to watch stands at $0.6922. Second resistance stands at $0.7241. The third major resistance level sits at $0.7661. If the price goes on to break the first support level at $0.6183, it is likely to go to the next support level at $0.5763. Assuming the price breaks the second support level, the third support level stands at $0.5444.
Atossa Therapeutics Inc (NASDAQ: ATOS) Key Stats
With a market capitalization of 85.30 million, the company has a total of 129,171K Shares Outstanding. Currently, annual sales are 0 K while annual income is -25,500 K. The company’s previous quarter sales were 0 K while its latest quarter income was -8,690 K.
